Nalaganje...
Emerging biomarkers for cancer immunotherapy in melanoma
The treatment and prognosis of metastatic melanoma has changed substantially since the advent of novel immune checkpoint inhibitors (ICI), agents that enhance the anti-tumor immune response. Despite the success of these agents, clinically actionable biomarkers to aid patient and regimen selection ar...
Shranjeno v:
| izdano v: | Semin Cancer Biol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5851807/ https://ncbi.nlm.nih.gov/pubmed/28917578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2017.09.004 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|